The Future of Global Vaccines

Market Forecasts to 2015

Product Code GBI00016
Publication Date December 2009
Publisher GBI Research
Product Type Report
Pages 250
ISBN Number not applicable
Change currency
PDF £2,215.00 €2,667 $3,502 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

The Future of Global Vaccines

Market Forecasts to 2015

Summary

GBI Research, the leading business intelligence provider, has released its latest research 'The Future of Global Vaccines Market Forecasts to 2015, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis', which provides insights on the global vaccines sales, volume and price forecasts to 2015. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global vaccines market. The report analyzes the markets for vaccines in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

The scope of this report includes:

  • Annualized market data for the global vaccines market from 2000 to 2008, forecast forward to 2015.
  • Analysis of the metabolic disorder therapeutics market in the leading geographies of the world. This includes the US, the UK, Germany, France, Italy, Spain, and Japan
  • Market characterization data on the global vaccines market including market size, market share and annual cost of vaccination.
  • Key drivers and restraints that have a significant impact on the market
  • Competitive landscape of the global vaccines market. The key companies studied in this report are Novartis AG, Sanofi Pasteur, Merck & Co, GlaxoSmithKline and Pfizer Inc.
  • Key M&A activities and licensing agreements that have taken place between 2008 and 2009 in the global vaccines market.

Reasons to buy

The report will aid business development and marketing executives strategizing their product launches:

  • Build effective strategies to launch their pipeline products by identifying potential geographies.
  • Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps.
  • Develop key strategic initiatives by studying the key strategies of top competitors.
  • Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth.
  • Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class vaccines with more efficiency and better safety.

Contents

  • 1 Executive Summary
  • 2 Tables and Figures
    • 2.1 List of Tables
    • 2.2 List of Figures
  • 3 Introduction
    • 3.1 GBI Research Report Guidance
  • 4 The Future of Global Vaccines: Market Overview
    • 4.1 Vaccine Preventable Diseases
    • 4.2 Vaccine Manufacturing Process
  • 5 The Future of Global Vaccines: Global Market
    • 5.1 Market Forecasts
      • 5.1.1 Market Share by Disease Sectors
      • 5.1.2 Market Share by Geography
    • 5.2 Average Cost of Vaccination per Child
    • 5.3 Target Population
      • 5.3.1 Immunization Coverage
    • 5.4 Unmet Needs
    • 5.5 Market Trends
      • 5.5.1 Immunization Programs
      • 5.5.2 Public-Private Partnerships
      • 5.5.3 Production Capacity
      • 5.5.4 Reimbursements
    • 5.6 Drivers
    • 5.7 Barriers
  • 6 The Future of Global Vaccines: The US Market
    • 6.1 Market Overview
    • 6.2 Market Forecasts
    • 6.3 Average Cost of Vaccination per Child
    • 6.4 Immunization Schedule
    • 6.5 Regulatory Framework
    • 6.6 Vaccine Procurement
    • 6.7 Vaccine Stockpiling
  • 7 The Future of Global Vaccines: European Market
    • 7.1 Market Overview
    • 7.2 Market Forecasts
    • 7.3 Average Cost of Vaccination per Child
    • 7.4 The United Kingdom
      • 7.4.1 Immunization Schedule
      • 7.4.2 Regulatory Framework
      • 7.4.3 Vaccine Procurement
      • 7.4.4 Vaccine Stockpiling
    • 7.5 France
      • 7.5.1 Immunization Schedule
      • 7.5.2 Regulatory Framework
      • 7.5.3 Vaccine Procurement
      • 7.5.4 Vaccine Stockpiling
    • 7.6 Germany
      • 7.6.1 Immunization Schedule
      • 7.6.2 Regulatory Framework
      • 7.6.3 Vaccine Procurement
      • 7.6.4 Vaccine Stockpiling
    • 7.7 Italy
      • 7.7.1 Immunization Schedule
      • 7.7.2 Regulatory Framework
      • 7.7.3 Vaccine Procurement
      • 7.7.4 Vaccine Stockpiling
    • 7.8 Spain
      • 7.8.1 Immunization Schedule
      • 7.8.2 Regulatory Framework
      • 7.8.3 Vaccine Procurement
      • 7.8.4 Vaccine Stockpiling
  • 8 The Future of Global Vaccines: Rest of the World
    • 8.1 Market Overview
    • 8.2 Market Forecasts
    • 8.3 Average Cost of Vaccination per Child
    • 8.4 Immunization Schedule
    • 8.5 Regulatory Framework
    • 8.6 Vaccine Procurement
    • 8.7 Vaccine Stockpiling
  • 9 The Future of Global Vaccines: Global Rotavirus Vaccine Market
    • 9.1 Market Overview
    • 9.2 Market Forecasts
    • 9.3 Average Cost of Vaccination
    • 9.4 Immunization Schedule
    • 9.5 Target Population
      • 9.5.1 Immunization Coverage
    • 9.6 Product Analysis
      • 9.6.1 RotaTeq
      • 9.6.2 Rotarix
    • 9.7 Vaccine Pipeline Analysis
  • 10 The Future of Global Vaccines: Global Pneumococcal Vaccine Market
    • 10.1 Market Overview
    • 10.2 Market Forecasts
    • 10.3 Average Cost of Vaccination
    • 10.4 Immunization Schedule
    • 10.5 Target Population
      • 10.5.1 Immunization Coverage
    • 10.6 Product Analysis
      • 10.6.1 Prevnar
      • 10.6.2 Synflorix
    • 10.7 Vaccine Pipeline Analysis
  • 11 The Future of Global Vaccines: Global Human Papillomavirus Vaccine Market
    • 11.1 Market Overview
    • 11.2 Market Forecasts
    • 11.3 Average Cost of Vaccination
    • 11.4 Immunization Schedule
    • 11.5 Target Population
      • 11.5.1 Immunization Coverage
    • 11.6 Product Analysis
      • 11.6.1 Gardasil
      • 11.6.2 Cervarix
    • 11.7 Vaccine Pipeline Analysis
  • 12 The Future of Global Vaccines: Global Seasonal Flu Vaccine Market
    • 12.1 Market Overview
    • 12.2 Market Forecasts
    • 12.3 Average Cost of Vaccination
    • 12.4 Immunization Schedule
    • 12.5 Target Population
      • 12.5.1 Immunization Coverage
    • 12.6 Product Analysis
    • 12.7 Vaccine Pipeline Analysis
  • 13 The Future of Global Vaccines: Competitive Landscape
    • 13.1 Overview
    • 13.2 Market Share Analysis
    • 13.3 Competitor Profiles
      • 13.3.1 Sanofi Pasteur MSD
      • 13.3.2 Merck
      • 13.3.3 GlaxoSmithKline (GSK)
      • 13.3.4 Novartis
      • 13.3.5 Pfizer
      • 13.3.6 Sanofi Pasteur
  • 14 The Future of Global Vaccines: Strategic Consolidations
    • 14.1 Mergers and Acquisitions
    • 14.2 Licensing Agreements
  • 15 Appendix
    • 15.1 Market Definitions
    • 15.2 Key Support Data
    • 15.3 Abbreviations
    • 15.4 Methodology
      • 15.4.1 Coverage
      • 15.4.2 Secondary Research
      • 15.4.3 Primary Research
      • 15.4.4 Expert Panel Validation
    • 15.5 Contact Us
    • 15.6 Disclaimer
  • List of Tables
    • Table 1: Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016
    • Table 2: Vaccines Market, Global, Market Share by Disease Segment, 2009
    • Table 3: Vaccines Market, Global, Target Population for Pediatric Vaccines, 2007-2016
    • Table 4: Vaccines Market, Global, Target Population for Adult Vaccines, 2007-2016
    • Table 5: Vaccines Market, Global, Immunization Coverage for Key Vaccines, 2007-2009
    • Table 6: Vaccines Market, The US, Revenue Forecasts ($bn), 2007-2016
    • Table 7: Vaccines Market, The US, Average Cost of Vaccination Per Child ($), 2009
    • Table 8: Vaccines Market, Europe, Revenue Forecasts ($bn), 2007-2016
    • Table 9: Vaccines Market, Europe, Average Cost of Vaccination per Child ($), 2009
    • Table 10: Vaccines Market, Rest of the World, Revenue Forecasts ($bn), 2007-2016
    • Table 11: Vaccines Market, Rest of the World, Average Cost of Vaccination per Child ($), 2009
    • Table 12: Rotavirus Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016
    • Table 13: Rotavirus Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016
    • Table 14: Rotavirus Vaccines Market, Global, Target Population, 2007-2016
    • Table 15: Rotavirus Vaccines Market, Global, Comparison of Key Products, 2009
    • Table 16: Pneumococcal Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016
    • Table 17: Pneumococcal Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016
    • Table 18: Pneumococcal Vaccines Market, Global, Target Population, 2007-2016
    • Table 19: Pneumococcal Vaccines Market, Global, Comparison of Key Products, 2009
    • Table 20: HPV Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016
    • Table 21: HPV Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016
    • Table 22: HPV Vaccines Market, Global, Target Population, 2007-2016
    • Table 23: HPV Vaccines Market, Global, Comparison of Key Products, 2009
    • Table 24: Seasonal Flu Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016
    • Table 25: Seasonal Flu Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016
    • Table 26: Seasonal Flu Vaccines Market, Global, Target Population, 2007-2016
    • Table 27: Seasonal Flu Vaccines Market, Global, Comparison of Key Products, 2009
    • Table 28: Vaccines Market, Global, Top 3 M&A Deals, 2009
    • Table 29: Vaccines Market, Global, Licensing Deals by Phase, Discovery, 2009
    • Table 30: Vaccines Market, Global, Licensing Deals by Phase, Phase I, 2009
    • Table 31: Vaccines Market, Global, Licensing Deals by Phase, Phase II, 2009
    • Table 32: Vaccines Market, Global, Licensing Deals by Phase, Phase III, 2009
    • Table 33: Vaccines Market, Global, Licensing Deals by Phase, Filed for Approval, 2009
    • Table 34: Vaccines Market, Global, Licensing Deals by Phase, Approved, 2009
  • List of Figures
    • Figure 1: Vaccines Market, Global, Market Overview, 2009
    • Figure 2: Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016
    • Figure 3: Vaccines Market, Global, Market Share by Disease Segment, 2009
    • Figure 4: Vaccines Market, Global, Market Share by Geography, 2009
    • Figure 5: Vaccines Market, Global, Average Cost of Vaccination by Geography, 2009
    • Figure 6: Vaccines Market, Global, Target Population for Pediatric Vaccines, 2007-2016
    • Figure 7: Vaccines Market, Global, Target Population for Adult Vaccines, 2007-2016
    • Figure 8: Vaccines Market, Global, Immunization Coverage for Key Vaccines, 2007-2009
    • Figure 9: Vaccines Market, Global, Unmet Needs, 2009
    • Figure 10: Vaccines Market, Global, Drivers and Barriers, 2009-2016
    • Figure 11: Vaccines Market, The US, Revenue Forecasts ($bn), 2007-2016
    • Figure 12: Vaccines Market, The US, Average Cost of Vaccination Per Child ($), 2009
    • Figure 13: Vaccines Market, The US, Immunization Schedule, 2009
    • Figure 14: Vaccines Market, Europe, Revenue Forecasts ($bn), 2007-2016
    • Figure 15: Vaccines Market, Europe, Average Cost of Vaccination Per Child ($), 2009
    • Figure 16: Vaccines Market, The UK, Immunization Schedule, 2009
    • Figure 17: Vaccines Market, France, Immunization Schedule, 2009
    • Figure 18: Vaccines Market, Germany, Immunization Schedule, 2009
    • Figure 19: Vaccines Market, Italy, Immunization Schedule, 2009
    • Figure 20: Vaccines Market, Spain, Immunization Schedule, 2009
    • Figure 21: Vaccines Market, Rest of the World, Revenue Forecasts ($bn), 2007-2016
    • Figure 22: Vaccines Market, Rest of the World, Average Cost of Vaccination Per Child ($), 2009
    • Figure 23: Rotavirus Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016
    • Figure 24: Rotavirus Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016
    • Figure 25: Rotavirus Vaccines Market, Global, Target Population, 2007-2016
    • Figure 26: Pneumococcal Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016
    • Figure 27: Pneumococcal Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016
    • Figure 28: Pneumococcal Vaccines Market, Global, Target Population, 2007-2016
    • Figure 29: HPV Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016
    • Figure 30: HPV Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016
    • Figure 31: HPV Vaccines Market, Global, Target Population, 2007-2016
    • Figure 32: Seasonal Flu Vaccines Market, The US, Doses Produced and Distributed, 2000-2008
    • Figure 33: Seasonal Flu Vaccines Market, The US, Sales by Channel, 2008
    • Figure 34: Seasonal Flu Vaccines Market, The US, Production Share by Company, 2008
    • Figure 35: Seasonal Flu Vaccines Market, The US, Market Share by Provider Type, 2007
    • Figure 36: Seasonal Flu Vaccines Market, The US, Dose Volume (million), 2009
    • Figure 37: Seasonal Flu Vaccines Market, Global, Revenue Forecasts ($bn), 2007-2016
    • Figure 38: Seasonal Flu Vaccines Market, Global, Average Cost of Vaccination ($), 2007-2016
    • Figure 39: Seasonal Flu Vaccines Market, Global, Target Population, 2007-2016
    • Figure 40: Vaccines Market, Global, Market Share by Company, 2009
    • Figure 41: Vaccines Market, Global, Comparison of Competitor Revenues by Quarter ($m), 2009
    • Figure 42: Vaccines Market, Global, Competitive Benchmarking of Top Six Vaccine Players, 2009-2016
    • Figure 43: Vaccines Market, Global, Competitive Benchmarking of Key Vaccine Markets, 2009-2016
    • Figure 44: Vaccines Market, Global, Sanofi Pasteur MSD, Sales of Key Product Segments by Quarter, 2009
    • Figure 45: Vaccines Market, Global, Merck, Sales of Key Product Segments by Quarter, 2009
    • Figure 46: Vaccines Market, Global, GlaxoSmithKline, Sales of Key Product Segments by Quarter, 2009
    • Figure 47: Vaccines Market, Global, Novartis, Sales of Key Product Segments by Quarter, 2009
    • Figure 48: Vaccines Market, Global, Sanofi Pasteur, Sales of Key Product Segments by Quarter, 2009
    • Figure 49: Vaccines Market, Global, M&A Landscape by Deal Type, 2009
    • Figure 50: Vaccines Market, Global, M&A Deals by Geography, 2009
    • Figure 51: Vaccines Market, Global, M&A Deals by Value, 2009
    • Figure 52: Vaccines Market, Global, Licensing & Alliances by Phase, 2009
    • Figure 53: Vaccines Market, Global, Licensing & Alliances Geography, 2009
    • Figure 54: Vaccines Market, Global, Licensing & Alliances by Deal Value, 2009
    • Figure 55: Vaccines Market, Global, Licensing & Alliances by Indications, 2009
    • Figure 56: GBI Research Methodology